CClinicalTrials.gg
CompletedNCT01931774Updated Aug 29, 2013

Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris

An observational study in Acne Vulgaris, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-29.

Sponsored by Bezmialem Vakif University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
66
Ages
18 Years and older
Sex
All
01

Study summary

Acne vulgaris usually causes psychological distress, depression, and anxiety disorders that may impair neurocognitive functions such as memory, attention, psychomotor speed, and executive functions, which are also common psychiatric disorders in patients with acne.

The purpose of this study is to determine cognitive functioning in treatment naive acne patients, without a history of any psychiatric disorder.

02

Conditions studied

  • Acne Vulgaris

Keywords

  • acne vulgaris cognitive functions
03

In context

Acne Vulgaris

730 studies on the registry are indexed under Acne Vulgaris; 85 are open to participants now.

This study's enrollment of 66 is below the median of 90 across 81 observational studies indexed under Acne Vulgaris.

Browse Acne Vulgaris studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 345 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Acne patients referred to the dermatology outpatient clinic of our university and healthy controls matched with the patient group for age, gender and years of education. Controls will be taken from the general population

Eligibility criteria

Inclusion Criteria:

-

Exclusion Criteria:

The participants that had a symptom or a history of mental retardation (IQ \< 70), serious head trauma, seizures or any other mental disorder, and participants on any medical treatment will be excluded. Participants with a family history (first degree relatives) of schizophrenia, bipolar disorder or schizoaffective disorder will also be excluded to avoid the negative effect of these disorders on cognitive functions. The same exclusion criteria will also be applied to the control group.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
66 participants (actual)
Patient registry
No

Groups and cohorts

  • Acne Patients
  • Control Subjects

    From General Population

06

What researchers measure

Primary outcomes

  1. Cognitive functions

    Time frame: baseline

Secondary outcomes

  1. anxiety

    Time frame: baseline

Other outcomes

  1. depression

    Time frame: baseline

07

Study locations

1 site
  • Bezmialem Vakif University Hospital
    Istanbul, 34093, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01931774
Lead sponsor
Bezmialem Vakif University
Responsible party
Erdem Deveci (Ass.Prof., Bezmialem Vakif University) — Principal investigator
First posted
Aug 29, 2013
Start date
Apr 2013
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Aug 29, 2013

Study contacts

Erdem Deveci, Ass.Prof.
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion